The cost-effectiveness of upfront point-ofcare testing in the emergency department : a secondary analysis of a randomised, controlled trial by Goldstein, Lara Nicole et al.
Goldstein et al. Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine
         (2019) 27:110 
https://doi.org/10.1186/s13049-019-0687-2ORIGINAL RESEARCH Open AccessThe cost-effectiveness of upfront point-of-
care testing in the emergency department:
a secondary analysis of a randomised,
controlled trial
Lara Nicole Goldstein1,2* , Mike Wells2 and Craig Vincent-Lambert2Abstract
Background: Time-saving is constantly sought after in the Emergency Department (ED), and Point-of-Care (POC)
testing has been shown to be an effective time-saving intervention. However, when direct costs are compared,
these tests commonly appear to be cost-prohibitive. Economic viability may become apparent when the time-
saving is translated into financial benefits from staffing, time- and cost-saving. The purpose of this study was to
evaluate the cost-effectiveness of diagnostic investigations utilised prior to medical contact for ED patients with
common medical complaints.
Methods: This was a secondary analysis of data from a prospective, randomised, controlled trial in order to assess
the cost-effectiveness of upfront, POC testing. Eleven combinations of POC equivalents of commonly-used special
investigations (blood tests (i-STAT and complete blood count (CBC)), electrocardiograms (ECGs) and x-rays (LODOX®
(Low Dose X-ray)) were evaluated compared to the standard ED pathway with traditional diagnostic tests. The
economic viability of each permutation was assessed using the Incremental Cost Effectiveness Ratio and Cost-
Effectiveness Acceptability Curves. Expenses related to the POC test implementation were compared to the control
group while taking staffing costs and time-saving into account.
Results: There were 897 medical patients randomised to receive various combinations of POC tests. The most cost-
effective combination was the i-STAT+CBC permutation which, based on the time saving, would ultimately save
money if implemented. All LODOX®-containing permutations were costlier but still saved time. Non-LODOX®
permutations were virtually 100% cost-effective if an additional cost of US$50 per patient was considered
acceptable. Higher staffing costs would make using POC testing even more economical.
Conclusions: In certain combinations, upfront, POC testing is more cost-effective than standard diagnostic testing
for common ED undifferentiated medical presentations – the most economical POC test combination being the i-
STAT + CBC. Upfront POC testing in the ED has the potential to not only save time but also to save money.
Trial registration: ClinicalTrials.gov: NCT03102216.
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Point-of-Care (POC) tests – diagnostic tests that are
performed at or near the patient’s bedside – have been
touted as potential time-saving interventions to decrease
waiting times in the Emergency Department (ED) [1–3].
These tests can decrease the turnaround time of special
investigations thereby reducing delays which can cause
prolonged patient times in the ED [2, 4]. While these
POC time-savers are mostly reported in the literature as
being cost-prohibitive to implement when their direct
costs are compared to the traditional diagnostic testing,
the POC system costs have conversely also been re-
ported as being less expensive than central laboratory
costs in other studies [2, 5–7]. Recouping the personnel
costs from the time that is saved, however, may paradox-
ically mean that the more expensive POC tests have fi-
nancial benefit and therefore become an economically
viable option [2, 5]. The improved overall processing of
the patient as a result of the reduced turnaround times,
more rapid diagnosis and disposition could potentially
allow for fewer staff members to manage the same num-
ber of patients in the same time as using a conventional
system [2, 5, 8]. This would be an important potential
consideration when planning and optimising ED staffing.
Conventionally, special investigations such as blood
tests, electrocardiograms (ECGs) and radiological inves-
tigations take place after an ED doctor has evaluated a
patient. Both the patient and the doctor then need to
wait for the results of these tests before the doctor can
make a disposition decision for the patient. When con-
ventional testing is replaced with POC tests performed
upfront prior to doctor assessment, significant time-
saving has been demonstrated – this was our rando-
mised, controlled trial that provided the data on which
this secondary analysis is based [9]. Whether the time-
saving from this intervention could translate into
money-saving is important to determine. This informa-
tion would be useful for policy- and decision-makers
with regards to deciding whether to implement upfront,
POC testing in their EDs.
The aim of this study was to evaluate the cost-
effectiveness of common diagnostic investigations, in the
form of POC tests, performed prior to doctor assess-
ment, for patients presenting to the ED as a secondary
analysis of data obtained from our randomised con-
trolled trial [9].
Methods
Study design and setting
This was a secondary analysis of data from an
investigator-initiated prospective, randomised, controlled
trial. The original trial evaluated the time-saving poten-
tial of upfront, POC tests in the ED [9]. This secondary
analysis was conducted in order to assess the cost-effectiveness of the upfront POC testing. The trial was
conducted in the ED of a tertiary, academic hospital in a
metropolitan area of Johannesburg, South Africa. The
ED sees approximately 65,000 patients annually. The
hospital is a government-funded, public sector hospital
serving a region with a population of approximately one
million medium- to low-income people.
The study took place between 13 February and 29 June
2017.
Permission to conduct the study was granted by the
Research Ethics Committee of the Faculty of Health Sci-
ences of the University of Johannesburg (REC-01-185-
2016); the Human Research Ethics Committee of the
University of the Witwatersrand (M171086); South Afri-
can National Health Research Ethics Council (DOH-27-
0117-5628); and was registered as a clinical trial with the
South African National Health Research Database (GP_
2017RP57_655) as well as with clinicaltrials.gov
(NCT03102216). Written informed consent was ob-
tained from all patients. Patients were not paid for their
participation in this study nor did they incur any ex-
penses related to the study.
Selection of participants
During weekdays, all adult patients older than 18 years
who presented to the ED with various common medical
symptoms were eligible for inclusion in the study. The
medical symptom groups included were typical of the
so-called undifferentiated patient that may present to
the ED viz.
 “abdominal group” – patients who presented with
any form of abdominal pain and/or vomiting
 “chest group” – patients who presented with
dyspnoea, chest pain, cough and/or syncope
 “generalized body pain/weakness group” – patients
who presented with generalized body pain and/or
weakness
 “psychiatric group” –patients who presented with
psychosis, aggression, hallucinations and/or having
taken a drug overdose
Patients who required immediate resuscitation or who
were pregnant were not considered for inclusion.
Figure 1 demonstrates the methodology followed in
the study, showing the normal ED pathway compared to
the eleven POC pathways utilised during the study
period.
Block randomisation was done prior to study com-
mencement using www.randomizer.org – an online ran-
domisation tool. Randomisation was independent of the
nature of the patient presentation. Symptom categories
were represented equally in each POC block and all
twelve test pathways were assigned to each of the above
Fig. 1 The POC intervention workflows compared to the normal ED patient workflow
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domisation, data collection sheet sets were placed
upside-down in the order generated. After the patient
signed consent, either the research doctor or the re-
search assistant took the next data collection sheet in
the order supplied.
The patients were randomised to receive either the
normal ED workflow pathway (i.e. the control) or one
of the other eleven intervention POC pathways with
various combinations of one, two, three or four POC
tests (see Fig. 1). This was done in order to ascertain
whether any particular individual POC test or ifcertain combinations of POC tests could provide the
most benefit.
In the control pathway, after triage, consent and
randomisation, a doctor evaluated the patient. If
diagnostic tests were required, they were ordered as
indicated. All blood tests were performed according
to standard procedures in the on-site hospital la-
boratory and if the patient required a blood gas ana-
lysis, the doctor would perform this on one of two
blood gas analysers available in the ED (Cobas B 221
POC system, Roche Diagnostics or ABL800 Flex,
Radiometer). X-rays were performed in the radiology
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required.
The doctor would review the patient a second time
once the results of the diagnostic tests were available.
This was followed by the disposition decision.
In the enhanced, intervention POC pathways, if the
doctor deemed additional investigations over and above
the POC tests necessary, those tests were then per-
formed according to the ED standard procedures. Once
the additional results were subsequently available, the
patients were reviewed.
Patients were not subjected to any form of diagnostic
investigation that they would not most likely have re-
ceived by following the control pathway for each par-
ticular symptom group. The main difference between
the control workflow pathway and the enhanced, inter-
vention POC workflow permutations was that the tests
were performed in the ED at the so-called point-of-care
prior to the patient seeing the doctor for the first time.
Patient throughput time in the ED consists of adminis-
trative time and treatment time [10]. Table 1 contains
the definitions, possible confounders and solutions
employed in this study to overcome them in order to ac-
curately evaluate the effects of the POC tests on patient
time in the ED and therefore the impact on the cost-
effectiveness.
POC tests
The POC equivalents of commonly used special investi-
gations in the ED were chosen – details are provided in
Table 2. The POC testing was performed in a private cu-
bicle where the LODOX® (LOw-DOse X-ray) machine
was located within the ED. All other testing was done as
per standard procedure in the ED. Details of the direct
cost comparisons of the diagnostic tests and their POC
equivalents are depicted in Table 2.
POC costs
Costs for the POC blood tests were obtained from the
supplier. Capital and maintenance costs of equipment
were included in the prices of all tests whether POC or
control diagnostic tests therefore no indirect costs were
added. Discounting was not applied. Prices for theTable 1 Time frame definitions in the ED
Administrative time
Time from patient arrival to doctor evaluation
All patients go through the same process of opening a file and registering o
hospital system in our ED.
The administrative process can be substantially longer on some days than on
days. This would change the wait-times for the patients prior to them presen
the doctor and would confound the time measurements overall and therefo
on the cost analysis.
Only treatment time was evaluated.control pathway investigations were obtained from the
hospital laboratory (blood tests) and radiology depart-
ment (X-rays/LODOX®). The cost of the ECG was
equivalent in both pathways.
When comparing the costs of the intervention permu-
tations to the control group, the costs were calculated as
follows:Control group
All tests as ordered by the doctors were included e.g. if
the doctor ordered an ECG and a blood gas, only the
costs of those two tests were included for that particular
patient.Intervention POC permutation groups
The costs of the POC tests specific to the group PLUS
any additional tests that were ordered by the doctors
were included in the total cost e.g. If the doctor ordered
an x-ray for a patient who was in the i-STAT + CBC
group, the cost of the x-ray was then added to the total
cost for that patient.Staffing costs
The cost calculations were performed as per Schilling’s
recommendation [5]. Staffing was considered as evenly
distributed throughout the year and calculated using
doctor and nursing costs only. Using this method, the
cost of one minute of ED staffing was calculated to be
US$5.37, which is equivalent to US$0.75 per patient per
minute in our ED.Sample size calculation
The sample size estimation was based on the determin-
ation of the effect of workflow pathways within each
symptom group that were initially analysed. This re-
quired a two-way Analysis of Variance (ANOVA). Based
on the detection of at least a medium effect size (f = 0.25
or a 20% difference in times between groups) with 80%
power at the 5% significance level, a sample size of 864
patients was required.Treatment time
Time from doctor evaluation to disposition decision
n the After a disposition decision is made, the patient may or may
not timeously leave the ED.
other
ting to
re impact
Exit block may lead to a delay in the patient leaving the ED
even if a timeous disposition decision is made.
The disposition decision time was utilised.
Table 2 POC tests employed and cost comparisons between
the control pathway tests and their POC equivalents
Abbott Point-of-Care i-STAT® System
The i-STAT System utilises single-use i-STAT test cartridges (i-STAT, Ab-
bott Point of Care, Princeton, NJ, USA) with a handheld POC blood ana-
lyser. The CHEM8+ (sodium, potassium, chloride, total carbon dioxide,
ionised calcium, glucose, urea, creatinine, haematocrit, haemoglobin and
anion gap) and CG4+ (Lactate; pH; partial pressure carbon dioxide
(PCO2); partial pressure of oxygen (PO2); total carbon dioxide; bicarbon-
ate; base excess and oxygen saturation) were performed on venous
blood specimens.
Abbott CEL-DYN Emerald 22 benchtop haematology system
The CEL-DYN Emerald 22 benchtop haematology system was used. It is
capable of providing a POC Complete/Full Blood Count as well as a
white blood cell differential count.
ECG
Philips Pagewriter TC30 ECG machines were utilised to obtain the ECGs.
All patients randomised to receive an ECG received a standard 12-lead
ECG as well as a right-sided (V1R-V6R) and posterior (V7-V9) ECG. The
cost of the ECG was the same in both the control and the intervention
groups.
LODOX®
A Lodox Xmplar-dr was used by a radiographer to perform the LODOX®
(LOw-DOse X-ray) radiographs (chest and abdomen, antero-posterior
and lateral). The radiation exposure was approximately 339uGy per pa-
tient versus a standard chest and abdomen radiograph of approximately
5200uGy [11]. LODOX® is the radiological equivalent of a POC test as it
can provide a full body X-ray within 19 s without the patient leaving the
ED. Its utility in trauma patients is reasonably well-known but its use as
a diagnostic tool for non-trauma patients in the ED has not been evalu-
ated previously [12].
Diagnostic tests Cost Point-of-Care equivalent Cost
Complete Blood Count 4.57 CBC (CEL-DYN Emerald
22)
2.33
Urea, Creatinine,
Electrolytes
Blood Gas
17.89 i-STAT Chem8 CG4+ 27.61
X-ray 121.58 LODOX® 104.17
TOTAL $ 144.04a TOTAL $ 134.11a
$ Costs shown in US dollars for each individual test
CBC Complete Blood Count, ECG electrocardiogram, i-STAT i-STAT POC tests,
LODOX® Low-dose x-ray
aThe direct comparison of net costs for testing between the groups if the
costs of the tests alone are shown in isolation at face value i.e. what the cost
would be for a patient who received all the standard diagnostic tests
compared to a patient who received all the POC tests. It would cost $9.93 less
to have all the POC tests. This does not include the costs of other tests that
might be ordered (e.g. serum amylase or lipase tests)
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Treatment time was the main outcome measure for
assessing the effectiveness of POC interventions. A dif-
ference in treatment time of 20% was considered to be
clinically significant – this is higher than that utilised in
previous studies (9–18%) [2, 9].
The main outcome measure for the cost-effectiveness
of upfront, POC tests was the incremental cost effective-
ness ratio (ICER).
The ICER was expressed asICER ¼ C1 C2=E1 E2
where C1 and E1 are the cost and effect (time) in the
intervention group and C2 and E2 are the cost and effect
in the control group [13].
Statistical analysis
A cost-effectiveness plane was constructed by plotting
the effects on the horizontal axis and costs on the verti-
cal axis. Further analysis utilised a non-parametric boot-
strapping model. This model used the observed data for
each permutation which was inserted into an excel tem-
plate supplied by Barton et al [14]. For each bootstrap
sample, the mean incremental costs and effects were cal-
culated and repeated 1000 times. Incremental cost-
effectiveness acceptability curves were then calculated
from the bootstrap data across a range of increasing po-
tentially acceptable costs. This analysis excluded the ef-
fects of potential cost-saving related to staffing expenses.
Data analysis was carried out using SAS (version 9.4
for Windows). The 5% significance level was used for all
statistical analyses.
Results
There were 1134 patients enrolled in the trial. Consecu-
tive patients were included during the patient enrolment
periods – there was no patient selection. Five patients
refused to participate in the study. After exclusions,
1044 patients were randomised. Figure 1 summarises the
patient flow.
During data collection for the primary study, the out-
comes in the “psychiatric group” (n = 147) were found to
be very different from the other three symptom groups
in an interim analysis. The psychiatric patients were seen
almost immediately in most cases based on their “or-
ange” triage scores and commonly only needed a single
investigation viz. a blood gas analysis. From an ED-
throughput perspective it was already functioning opti-
mally and the extra testing was not required. Their data
was therefore excluded as it would have skewed the re-
sults from both a time- and cost perspective. Therefore,
897 patients were included in the analysis.
Ten patients presented to the ED on more than one
occasion during the study period and agreed to be en-
rolled a second time. They were treated no differently
from patients who were seen for the first time. They all
signed a new consent form and were randomised yet
again. Their inclusion was therefore unlikely to have in-
fluenced the study outcomes.
Patient characteristics
A comparison of patient characteristics based on work-
flow allocation is tabulated in Table 3. There were no
significant differences in age, triage category or
Table 3 Patient characteristics based on the twelve workflow allocations
CONTROL i-STAT i-STAT
CBC
ECG LODOX i-STAT
ECG
i-STAT
CBC
ECG
i-STAT
LODOX
i-STAT
CBC
LODOX
ECG
LODOX
i-STAT
ECG
LODOX
i-STAT CBC
ECG
LODOX
p-value for
between
group test
N 75 75 74 77 75 74 76 74 77 73 74 73
Age median
(IQR)
45.7
(34.2;
61.7)
45.2
(31.6;
59.3)
44.2
(33.3;
68.0)
44
(33.9;
61.0)
41.6
(33.0;
55.5)
41.9
(33.3;
56.6)
40.7
(27.3;
60.9)
42.1
(29.9;
60.8)
37.1
(30.0;
55.1)
44.9
(35.0;
60.5)
39.5
(30.0;
61.3)
41.3
(31.5;
55.6)
0.65
Sex: Males
(%)
30
(40.0)
30
(40.0)
29
(39.2)
36
(46.8)
30
(40.0)
27
(36.5)
35
(46.1)
18
(32.4)
28
(36.4)
31
(42.5)
42
(56.8)
37
(50.7)
0.11
Triage category 0.30
N (%)
Orangec 22
(29.3)
18
(24.0)
11
(15.1)
22
(28.6)
15
20.0)
16
(21.6)
24
(31.6)
18
(24.3)
22
(28.6)
14
(19.2)
18
(24.3)
21
(28.8)
Yellowc 52
(69.3)
54
(72.0)
59
(80.8)
52
(67.5)
60
(80.0)
57
(77.0)
50
(65.8)
54
(73.0)
55
(71.4)
59
(80.8)
56
(75.7)
48
(65.8)
Greenc 1
(1.3)
3
(4.0)
3
(4.1)
3
(3.9)
0
(0.0)
1
(1.4)
2
(2.6)
2
(2.7)
0
(0.0)
0
(0.0)
0
(0.0)
4
(5.5)
Admitteda b
N(%)
32
(42.7)
32
(42.7)
40
(54.1)
34
(44.2)
34
(45.3)
29
(39.2)
42
(56.0)
35
(47.3)
32
(41.6)
39
(53.4)
40
(54.1)
39
(53.4)
0.62
Dischargeda
N(%)
38
(50.7)
41
(54.7)
33
(44.6)
43
(55.8)
41
(54.7)
42
(56.8)
33
(44.0)
39
(52.7)
44
(57.1)
33
(45.2)
34
(45.9)
34
(46.6)
CBC Complete Blood Count, ECG Electrocardiogram, IQR inter-quartile range, i-STAT i-STAT POC tests, LODOX® Low-dose x-ray
a8.2% of all patients were referred to another speciality as their disposition plan (i.e. neither admitted nor discharged)
bThe overall admission rate for this ED is usually 30–35%. This includes all patient presentations e.g. trauma, general surgery, orthopaedics, otorhinolaryngology
etc. The medical subgroup of patients typically has a higher admission rate than other patients
cTarget times for the patients in each triage acuity category are Orange (to be seen within 10 min of ED arrival), Yellow (to be seen within 1 h of ED arrival) and
Green (to be seen within 4 h of ED arrival)
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trol or POC intervention groups.
Treatment times
A 20% reduction in treatment time was exceeded by all
POC workflow permutations, except ECG alone and
LODOX® alone groups.
With regards to disposition decision, there were no
significant differences in treatment times between pa-
tients who were ultimately admitted or discharged
within particular workflows, or between admission and
discharge within particular symptom groups (p = 0.091).
Time taken for POC testing and patient waiting times
The patient waiting time to see a doctor after arrival in
the ED was on average between 57 and 152 min. It took
between 4 and 23min to obtain the results of the POC
tests. This included the time taken for phlebotomy, spe-
cimen processing and results printing for the i-STAT
and CBC permutations. The blood tests could generally
be performed concurrently, however, the LODOX® and
ECGs had to be performed sequentially.
Investigation utilisation in the control pathway
There were 78.7% (59/75) patients in the control
group who had blood tests and/or a blood gasanalysis. Twenty-four per cent (36/75) had a blood
gas analysis only. X-rays were performed in 58.7%
(44/75) of patients and 64% (48/75) had ECGs
performed.Costs of investigations
Table 2 lists the costs for the individual investigations.
Overall, POC equivalent tests cost US $9.93 less than
the standard control investigations if all the tests were
performed in a patient.
The time-saving and costs for each workflow is pre-
sented in Table 4.Cost effectiveness analysis
Figure 2 exhibits the Cost Effectiveness Plane (2A),
which is a graphical representation of the cost effective-
ness analysis as well as the cost-effectiveness acceptabil-
ity curve (2B).
LODOX®-containing permutations (dashed lines) and
non-LODOX®-containing pathways (solid lines) are dem-
onstrated using different values for funder willingness-
to-pay (λ). Non-LODOX® permutations were virtually
100% cost-effective if an additional cost of US$50 per
patient was considered acceptable.
Table 4 Costs and time-saving analysis ranked according to net additional cost per patient
Total
Average
Group Costa
(US$ pp)
Difference between
costs of POC tests and
control
(US$ pp)
Time Saved – Difference between
control group time and POC group
time
(min)
Staffing costs
saved (US$
pp)
ICER - Incremental
Cost Effectiveness
Ratio
(US$ / min)
Net additional cost
per patient in POC
group
(US$ pp)
CONTROL 81.86 – – – – –
i-STAT +
CBC
82.86 1.00 31 23.21 0.03 −22.21
ECG ONLY 75.96 −5.90 9 6.74 −0.65 −12.63
i-STAT +
CBC + ECG
90.73 8.87 26 19.47 0.34 −10.60
i-STAT 92.59 10.73 21 15.72 0.51 −4.99
i-STAT +
ECG
95.36 13.50 21 15.72 0.64 −2.22
ECG +
LODOX
127.48 45.62 25 18.72 1.82 26.90
i-STAT +
ECG +
LODOX
143.11 61.25 32 23.96 1.91 37.29
ALL POC
TESTS
144.10 62.24 31 23.21 2.01 39.03
i-STAT +
LODOX
142.56 60.70 25 18.72 2.43 41.98
i-STAT +
CBC +
LODOX
146.74 64.88 27 20.22 2.40 44.67
LODOX
ONLY
142.09 60.23 9 6.74 6.69 53.49
$ Costs shown in US dollars for each permutation
A negative number indicates a lower cost with the POC test permutation than traditional diagnostic testing
CBC Complete Blood Count, ECG electrocardiogram, ICER incremental cost effectiveness ratio, i-STAT i-STAT POC tests, LODOX® Low-dose x-ray, pp per patient
aThese are the average total actual costs that were incurred for the patients in each permutation. In the Control group, the only tests that were included were
those selected by the doctors as they saw fit. In other groups, the average costs appear to be higher than would be expected as extra diagnostic tests may have
been performed in those groups over and above those which were assigned (e.g. additional blood tests such as serum amylase or lipase). This principle extends
across each of the groups
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Saving time is an ever-present goal in the ED. However,
for upfront POC testing to be viable in the ED, the
time-saving benefit needs to be weighed against the
cost.
Costs of investigations and cost effectiveness analysis
Variations have been reported with respect to the net
cost of POC testing [5, 8, 13]. In Sweden, POC was
found to be substantially cheaper than the costs of simi-
lar tests performed in a laboratory [5]. In Australia, how-
ever, test costs were higher in the POC group [6]. Costs
have previously been calculated using the direct differ-
ences between that of the POC tests and the laboratorycosts without taking the expense of personnel into ac-
count [8]. The cost of staffing needs to be taken into ac-
count as decreases in test turnaround time could be
translated into savings in staffing due to an improved
overall processing of the patient from decreased turn-
around times as well as quicker diagnosis and ultimately
more rapid patient disposition [2, 5, 8].
In our study, direct head-to-head cost comparison be-
tween the POC tests compared to standard laboratory
and radiological expenses in our study surprisingly
showed a saving of US$9.93 if all the tests had been per-
formed on all patients compared to using standard diag-
nostic tests. This was mainly as a result of the lower cost
of the LODOX® compared to the x-ray and the lower
Fig. 2 a Cost Effectiveness Plane. Permutations in the south-east quadrant were less costly and more effective (also referred to as dominant) [13].
Permutations in the north-east quadrant were still more effective but were also costlier. b Cost-Effectiveness Acceptability Curve. Cost-
effectiveness acceptability curves for each of the permutations. The proportion of the bootstrap datapoints achieving cost-effectiveness at each
increment of potentially acceptable cost is shown. Permutations which included LODOX® are shown with dashed lines. The dotted lines
represent two potential willingness-to-pay thresholds. For example, at US$50, virtually all the non-LODOX® permutations have a high probability
of being cost-effective. On the other hand, at a willingness-to-pay threshold of US$30, only the iSTAT and the ECG permutations have a high
probability of being cost-effective. This graph allows the funder to weigh the relative cost of each of the permutations against their known
effectiveness. CBC Complete Blood Count, ECG electrocardiogram, i-STAT i-STAT POC tests, LODOX® Low-dose x-ray
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Although this comparison of total costs appeared prom-
ising, it was necessary to look at the cost-effectiveness of
the individual permutations.When evaluating the cost:benefit ratio for POC testing,
it is essential to include the disbursements on staffing.
The time a doctor spends with the patient has a cost – if
this time can be decreased with POC testing then the
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effectiveness evaluation [2, 5, 8]. When personnel costs
and time-saving were both considered, the net additional
savings increased further, with the true benefit of certain
test combinations being highlighted.
In Fig. 2, it can be seen that all LODOX®-containing
permutations fell into the north-east “more costly but
more effective” quadrant. X-ray and LODOX® costs
formed the bulk of the expenses related to the diagnostic
testing combinations making all the LODOX®-containing
options more costly. LODOX® therefore added substan-
tially to the cost, without much additional time-saving.
Also, only 58.7% of the control group had an x-ray per-
formed while 100% of the participants in the respective
LODOX® permutations received an x-ray. This lead to
an overall additional comparative cost per patient com-
pared to the control group despite LODOX® being more
inexpensive than a standard x-ray. The addition of a
LODOX® in a protocolised fashion may need to be re-
evaluated and may perhaps be more valuable if intro-
duced only after an admission decision is made. Indis-
criminate use of LODOX® on all patients irrespective of
whether they require hospital admission would lead to
over-testing and unnecessary radiation exposure even if
it is relatively low-dose radiation. Some patients also re-
ceived a formal x-ray in addition to their LODOX®
which increased costs and so was a confounder for the
LODOX®-containing groups overall.
While the ECG only group was cost-effective because
of a direct saving of US$5.90 per patient, the lack of sig-
nificant time-saving makes it ineffectual to assist with
ED throughput.
The most cost-effective combination, which ultimately
would save money based on the time-saving, was the i-
STAT + CBC permutation. It was second in time-saving
to i-STAT + ECG + LODOX® by one minute and equiva-
lent in saving time to the combination where the pa-
tients had all the tests performed. The latter two
permutations would require additional spending in order
for them to be implemented. With one-third of patients
having laboratory testing in general in the ED, the i-
STAT + CBC option would fulfil the dual purpose of de-
mand and cost-effectiveness [15, 16].
The impact of staffing costs
Staffing costs play a significant role in the calculation of
cost effectiveness. In a Swedish ED, Schilling showed a
significantly higher cost saving than in our study. This
was largely due to their higher cost of staffing
(US$24.08/min versus our US$5.37/min) [5]. A higher
staffing cost would mean that time saved using POC
testing is ultimately even more economical. The time-
saving could potentially also be used to offset staffing
costs. There may be an opportunity to reduce staffinglevels based on reduced treatment times offered by the
POC tests. Optimisation of patient processing means
that the costs of staffing need to be taken into consider-
ation [5].Value for money – cost-effectiveness acceptability
Permutations in the north-east quadrant of the cost-
effectiveness plane were more effective than the control
but were also costlier. The determination of whether an
intervention offers “good” value for money depends on
the funder’s willingness to pay (λ) [17]. The range of po-
tential amounts that the funder may be considering are
displayed on the x-axis of the cost-effectiveness accept-
ability curve and can be judged according to the relative
probability that an intervention will be cost-effective
shown on the y-axis. Figure 2B demonstrates this con-
cept with the majority of the permutations still most
likely to be cost-effective at a willingness to pay thresh-
old of US$50, except for those permutations containing
LODOX®.
Non-LODOX® permutations were virtually 100% cost-
effective if an additional cost of US$50 per patient was
considered acceptable by funders.
This model has been used in previous studies on
healthcare cost-effectiveness [13, 14, 17]. It is tool that
allows decision-makers to balance up costs against non-
quantifiable benefits. For example, a reduced waiting
time might not have any direct cost implications, but
will increase patient satisfaction. A funder might be will-
ing to pay a small additional amount for this but not a
large amount. This tool therefore allows the potential
funder to better balance the benefits and costs. It also al-
lows the funder to balance quantifiable costs e.g. the de-
cision whether to close a diagnostic laboratory at night
in favour of utilising POC tests.Waiting times and special investigation use in the ED
Waiting for the results of special investigation such as
blood tests, ECGs and radiographs commonly takes two-
thirds of a patient’s entire ED length of stay [15]. A sub-
stantial amount of time could potentially be saved if
these test results were available prior to the doctor’s ini-
tial evaluation of the patient. In this study, waiting for
results of the intervention POC tests was concurrent
with the patients’ wait to be seen by a doctor (minimum
waiting time 57min). This meant that the time taken to
perform the POC tests (maximum 23min) did not cause
any significant delays for the patients as it took place
during non-valued added time when the patients were
waiting to see the doctor.
In Yoon’s analysis of factors increasing length of stay
in the ED in Canada, 38.4% of patients had laboratory
tests and 44% underwent some form of X-ray imaging.
Goldstein et al. Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine          (2019) 27:110 Page 10 of 12These interventions were associated with longer lengths
of stay [15]. In the USA, Gardner et al. found that 33%
of patients had laboratory investigations (increasing
length of stay by 35.4 to 40.1 min) and 36% had x-rays
(increased by 5 to 15 min) [18]. Thirty per cent of dis-
charged patients in a Finnish study by Kankaanpää et al.
needed laboratory testing [19]. The laboratory usage in
our control group of 30% (excluding patients who had
blood gas analyses alone) is similar to the utilisation in
these other EDs. The x-ray utilisation rate was higher,
however. This may have been due to the higher admis-
sion rate at our hospital of 42.7% (versus 11% in the
Gardner study) as all patients admitted to the internal
medicine service receive an x-ray.
All patients in an i-STAT-containing subgroup in our
study showed a decreased treatment time. Although the
performance of a LODOX® scan took only on average
four and a half minutes, time-saving was only achieved
when it was combined with other POC tests. This was
similar to the time-saving gained by the performance of
an upfront ECG. Gardner et al. found that ECGs only
saved time (2.7 min) in those patients who were admit-
ted but added time in patients who were ultimately dis-
charged [18]. In our study, there was no difference in
the number of tests performed regardless of disposition
decision i.e. whether a patient was ultimately admitted
to the hospital or discharged.Standing orders versus upfront POC testing and “over-
testing”
In the ED, standing orders have been shown to improve
patient throughput by reducing disposition time by up
to 16.9% [20]. However, these orders are usually only
actioned if the ED is full; have had variable uptake by
the nursing staff resulting in both over- and under-
testing and have not made use of POC devices [16, 20].
Over-testing is frequently quoted as a danger when
standing orders are in place or when POC testing is
made easily available. There is, however, no evidence to
support this [16, 21–23]. In Retezar’s study evaluating
triage standing orders, those patients who received the
full gamut of tests had a 16% reduction in their mean
treatment times. The hypothesis that upfront, protoco-
lised testing leads to over-testing is nullified by her study
findings where 98 % of the patients who did not receive
the standing orders went on to receive similar investiga-
tions once they were seen by a doctor [24]. The cost of
POC usage would therefore be unlikely to be exagger-
ated compared to standard diagnostic test utilisation. In
our study, over-testing was possible in the patients who
were ultimately admitted to the internal medicine ser-
vice. Blood tests are commonly performed as a courtesy
for those patients even if the results do not impact onthe ED disposition decision. These were extra standard
blood tests and not POC tests.
Other potential cost implications
Besides these direct costs, there is also the potential for
further cost-saving that may be possible by reducing ad-
mission rates. In Fitzgerald et al’s RATPAC trial, which
focussed on patients with chest pain in suspected myo-
cardial infarction, POC testing was associated with
higher ED costs but lower general inpatient costs [7].
Other non-fiscal “cost savings” should also be evalu-
ated in future POC cost-effectiveness analyses. Although
we did not collect data on the patient experience, we ac-
knowledge that their input would have been useful as
part of the overall impact of the intervention. The very
low refusal rate may have suggested that patients
favoured this system, but no direct data were collected.
The doctors’ perceptions of the effectiveness and ap-
propriateness of the upfront POC testing were evaluated
as part of this study. They were strongly supportive of
the intervention [25].
Further possible positive effects which need to be
quantified include the beneficial knock-on effects of de-
creases in patient complaints due to excess waiting
times, increases in staff satisfaction, and the potential for
fewer patients leaving the ED without being seen. This
will require future investigation.
Patient sub-groups that could benefit from upfront POC
testing
Although the symptom groups originally included in the
study characterised typical categories of undifferentiated pa-
tients that present to the ED, interim analysis highlighted
that the “psychiatric group” was already functioning opti-
mally based on their high acuity triage scores as well as the
limited special investigations that they required for safe pa-
tient disposition. The use of upfront POC testing in this
group of patients would therefore have no time- or cost
benefit. Upfront testing appeared to be most appropriate
for the undifferentiated medical patient and the ultimate
cost-effectiveness in any ED would depend on the case mix
presenting to that ED.Hospital admission rates and patient acuity
There was no difference between the patients who were
admitted to the hospital (sicker patients) compared to
those who were discharged from the ED (less ill pa-
tients). Both groups of patients benefited from the up-
front testing. The overall percentage of patients
admitted from the ED was higher than the usual admis-
sion rate of the ED of 30–35% (Table 3). These higher
admission rates are likely related to the fact that only
medical patients were included who, in general, are
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are also the patient group that would potentially benefit
most from upfront POC testing. Therefore, it is unlikely
that the high level of significant illness was an important
source of bias in this study. There was a range of triage
categories within each group (not significantly different)
that further suggests that this was not an important bias.
Furthermore, upfront POC testing is not suggested to be
used in all patients presenting to the ED. Clearly some
patients would not benefit (e.g. minor orthopaedic injur-
ies), but it would be best applied to patients with undif-
ferentiated medical presentations. This does mean,
however, that EDs that see very few sick patients would
benefit less from upfront POC testing.Limitations
This single-centre study evaluated the impact of POC on
the treatment time but there was no data collected nor as-
sessment of the effect on patient outcome and potential ad-
verse effects of universal testing. However, in previous POC
studies, there has been no evidence to support the theory of
over-testing [16, 21–23]. The patient medical complaints
were heterogeneous. Whilst they were common symptoms
in our ED, they may not be representative of other EDs.
This was notable with regards to the low incidence of acute
coronary syndrome-related chest pain. POC troponin was
originally included as one of the i-STAT tests used in our
study. Although troponin has been shown to be useful for
patients with chest pain or suspected acute coronary syn-
drome in the ED as well as the presence of raised troponin
levels having an association with worse short-term clinical
outcomes, we ultimately excluded it for the cost-
effectiveness analysis as there would be no benefit for our
ED population and would have resulted in over-testing [26,
27]. Similarly, the indiscriminate use of D-dimer testing in
this heterogenous population without employing pre-test
probability scoring could potentially have been harmful and
could also have resulted in over-testing. Therefore D-dimer
testing was not included in the upfront testing. As the ED
doctors were not blinded to which patients received the up-
front POC tests, a Hawthorne-type effect was considered,
but there was no evidence to support it. However, as the
doctors themselves were recording all the times (and not
an impartial observer), this could have been a potential
source of error. Due to the funding of allied hospital staff
being managed separately, staffing costs were calculated
using doctor and nursing costs only. The costs related to x-
rays and LODOX® were based on the standard prices
charged per patient per investigation as opposed to calcula-
tions based on the equipment amortisation costs. The dif-
ferent setup costs of a laboratory and of a POC system
were also not taken into account. The performance of “ad-
mission tests” for the internal medicine service may havealso confounded the diagnostic test utilisation. This may
have lead to duplication of tests if the patient was admitted.
Conclusion
POC testing in the ED was more cost-effective, in
certain combinations, than standard diagnostic tests
when utilised upfront for patients with undifferenti-
ated common medical complaints in non-resuscitation
triage categories. The most economical POC test
combination was i-STAT + CBC, which not only
saved time, but, also saved the most money per pa-
tient. Besides these direct costs, there is also the po-
tential for further cost-saving that may be possible by
reducing hospital admission rates as well as the other
non-fiscal “cost savings”. These should be evaluated
in future POC cost-effectiveness analyses.
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